News

CSL Behring‘s HEMOPEXIN FIRST IN HUMAN STUDY IN STABLE SICKLE DISEASE Study Title: A Phase 1, Multi-Center, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CSL889 in Adult Patients with Stable Sickle Cell Disease ClinicalTrial.gov: NCT04285827 Click this link to view trial

Thalassaemia Questionnaire

If your a patient that suffers from Sickle Cell or Thalassaemia or even knows somebody that does, then we would love to hear from you. STSTN are looking for articles that we can publish in our summer edition newsletter which is due to be published by the end of June 2o21. All articles are to …

PATIENT ARTICLES WANTED FOR OUR SUMMER NEWSLETTER! Read More »